Skip to content

Smart Port CT CT80STPA-VIRecalls & reported problems

Angiodynamics, Inc. · Smart Port CT Single Titanium Port System with Attached 8.0F x 66cm Polyurethane Catheter and 8 F Introducer Kit (with Valved Introducer) · Class 2 · Implant

All models of Smart Port CT (36)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI H787CT80STPAVI1), received between Apr 20, 2017 and Apr 20, 2017 — classified as 2 injuries, 6 malfunctions.

The most frequently reported specific device problem is “Fracture” (8 reports).

2 other recalls cover devices cleared under the same FDA submission (K062414); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Fracture8
  • Leak/Splash8

Patient problems

  • No Known Impact Or Consequence To Patient8
  • Pain8

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON (B)(6) 2017: WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508050 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON (B)(6) 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USED WEEKLY. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508026 ↗
  • InjuryApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH 22, 2017: WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508022 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH 22, 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USE EVERY 4 WEEKS. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508021 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH 22, 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USE EVERY 4 WEEKS. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508011 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH 22, 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USE EVERY WEEK. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6508008 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH (B)(6) 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USE EVERY 2 WEEKS. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED AND REPLACED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6507993 ↗
  • MalfunctionApr 20, 2017Fracture; Leak/Splash; Fracture; Leak/Splash

    AS REPORTED TO ANGIODYNAMICS ON MARCH 22, 2017: PATIENT WAS RECEIVING CHEMOTHERAPY VIA PORT. THE PORT WAS FLUSHED 6-8 WEEKS IF NOT IN USE. THIS PORT WAS CURRENTLY IN USE EVERY 2 WEEKS. WHEN FLUSHING THE PORT, THE PATIENT REPORTED EXPERIENCING SLIGHT PAIN. IT WAS NOTED THE PORT CATHETER HAD FRACTURED. IT WAS REPORTED THE DEFECTIVE DEVICE WAS REMOVED AND REPLACED. THE PATIENT DID NOT SUFFER ANY ADVERSE EFFECT DUE TO THIS EVENT. IT WAS REPORTED THAT THE DISPOSABLE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.

    Patient problems: No Known Impact Or Consequence To Patient; Pain

    MAUDE report 6507981 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K062414. One submission often covers many models, so check the product and lot details in each record.

  • Z-1466-2021 · Feb 22, 2021 · Terminated
    Smart Port CT-Implantable Port Catalogue #: CT96STSD-VI, CT96STSA-VI - Product Usage: indicated for any patient requiring repeated access of the vascular system, for delivery of me
  • Z-0056-2012 · Aug 1, 2011 · Terminated
    8F Smart Port CT, Catalog number: CT80STPD and CT80STPD-NF; AngioDynamics, INC. The Smart Port CT Implantable Port is a Single Titanium Port System with Attachable 8.0 Fr. Polyur

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page